{"id":"W4412891969","doi":"10.1093/cid/ciaf424","title":"2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness","year":2025,"lang":"en","type":"article","venue":"Clinical Infectious Diseases","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Impact","funders":"National Institutes of Health; Department of Health and Human Services, State Government of Victoria; Instituto Nacional do Câncer, Ministério da Saúde; Infectious Diseases Society of America","keywords":"Medicine; Guideline; Abatacept; Intensive care medicine; Coronavirus disease 2019 (COVID-19); Grading (engineering); Clinical Practice; Family medicine; Internal medicine; Infectious disease (medical specialty); Pathology; Rituximab; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02080288,0.001794163,0.004580087,0.00850276,0.001516712,0.004513558,0.005222969,0.009603458,0.01028043],"category_scores_gemma":[0.08977274,0.001822702,0.008606654,0.006753617,0.001256397,0.003206324,0.00316157,0.009735332,0.008350561],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007317561,"about_ca_system_score_gemma":0.031289,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02892078,"about_ca_topic_score_gemma":0.05804277,"domain_scores_codex":[0.976913,0.008461026,0.007484321,0.0008077922,0.005642959,0.0006908873],"domain_scores_gemma":[0.9143286,0.02618949,0.01572165,0.001263919,0.03933554,0.003160886],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001040785,0.00008974972,0.0006937204,0.02329789,0.0006370062,0.0001892735,0.0002514324,0.0002818005,0.0003596829,0.001713118,0.8467081,0.1256741],"study_design_scores_gemma":[0.0008302218,0.0001516141,0.003969994,0.1353974,0.0028274,0.0006215074,0.0002168621,0.0004597272,0.0003337726,0.003863402,0.851193,0.0001350794],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"methods","genre_scores_codex":[0.002088979,0.3444691,0.018597,0.4558995,0.05211352,0.02377954,0.03440532,0.0009293218,0.06771771],"genre_scores_gemma":[0.01164735,0.4559259,0.1732562,0.226598,0.01986564,0.03146254,0.049408,0.0004760471,0.03136036],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.02892078,"threshold_uncertainty_score":0.1100175,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05066346205346342,"score_gpt":0.4980148481014235,"score_spread":0.4473513860479601,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}